Cells (Oct 2022)

Therapeutic Strategies for Restoring Perturbed Corneal Epithelial Homeostasis in Limbal Stem Cell Deficiency: Current Trends and Future Directions

  • Faisal Masood,
  • Jin-Hong Chang,
  • Anosh Akbar,
  • Amy Song,
  • Wen-Yang Hu,
  • Dimitri T. Azar,
  • Mark I. Rosenblatt

DOI
https://doi.org/10.3390/cells11203247
Journal volume & issue
Vol. 11, no. 20
p. 3247

Abstract

Read online

Limbal stem cells constitute an important cell population required for regeneration of the corneal epithelium. If insults to limbal stem cells or their niche are sufficiently severe, a disease known as limbal stem cell deficiency occurs. In the absence of functioning limbal stem cells, vision-compromising conjunctivalization of the corneal epithelium occurs, leading to opacification, inflammation, neovascularization, and chronic scarring. Limbal stem cell transplantation is the standard treatment for unilateral cases of limbal stem cell deficiency, but bilateral cases require the use of cultured non-limbal autologous stem cell or allogeneic limbal stem cell transplantation. Herein we review the current therapeutic utilization of limbal stem cells. We also describe several limbal stem cell markers that impact their phenotype and function and discuss the possibility of modulating limbal stem cells and other sources of stem cells to facilitate the development of novel therapeutic interventions. We finally consider several hurdles for widespread adoption of these proposed methodologies and discuss how they can be overcome to realize vision-restoring interventions.

Keywords